Metraipolis › archive › dc_2535bb94bb91

Optimising Meropenem and Piperacillin Dosing in Patients Undergoing Extracorporeal Membrane Oxygenation Without Renal Dysfunction (MEPIMEX) — Europe PMC PMID:41009917

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41009917
DOI
10.3390/antibiotics14090939
License (as archived)
solo-consultazione
Archived
2026-11-09T21:33:44.952Z
SHA-256 of the archived text
d73b1017caf39f7743b1815260c9e8c4fbe09c652017389ef3bef11e6fe3d1b3
Stable URL of this page
https://metraipolis.com/documento/dc_2535bb94bb91

How to cite

Optimising Meropenem and Piperacillin Dosing in Patients Undergoing Extracorporeal Membrane Oxygenation Without Renal Dysfunction (MEPIMEX) — Europe PMC PMID:41009917 — Europe PMC (en), https://europepmc.org/article/MED/41009917 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2535bb94bb91 (Metraipolis archive dc_2535bb94bb91, sha256 d73b1017caf39f7743b1815260c9e8c4fbe09c652017389ef3bef11e6fe3d1b3)
BibTeX
@misc{dc2535bb94bb91,
  title = {Optimising Meropenem and Piperacillin Dosing in Patients Undergoing Extracorporeal Membrane Oxygenation Without Renal Dysfunction (MEPIMEX) — Europe PMC PMID:41009917},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41009917},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2535bb94bb91; sha256 d73b1017caf39f7743b1815260c9e8c4fbe09c652017389ef3bef11e6fe3d1b3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41009917. Agents can read the archived copy with the MCP tool read_document.